nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—HTR1F—trigeminal nerve—head and neck cancer	0.116	0.337	CbGeAlD
Rizatriptan—HTR1B—trigeminal nerve—head and neck cancer	0.0477	0.138	CbGeAlD
Rizatriptan—HTR1D—trigeminal nerve—head and neck cancer	0.0462	0.134	CbGeAlD
Rizatriptan—Arteriospasm coronary—Fluorouracil—head and neck cancer	0.0399	0.0612	CcSEcCtD
Rizatriptan—HTR1B—cranial nerve—head and neck cancer	0.034	0.0984	CbGeAlD
Rizatriptan—HTR1D—cranial nerve—head and neck cancer	0.0329	0.0953	CbGeAlD
Rizatriptan—Pain in jaw—Vinblastine—head and neck cancer	0.0271	0.0415	CcSEcCtD
Rizatriptan—Ischaemia—Vinblastine—head and neck cancer	0.0242	0.0371	CcSEcCtD
Rizatriptan—Colitis ischaemic—Docetaxel—head and neck cancer	0.0142	0.0218	CcSEcCtD
Rizatriptan—Dysaesthesia—Fluorouracil—head and neck cancer	0.0134	0.0205	CcSEcCtD
Rizatriptan—Photopsia—Docetaxel—head and neck cancer	0.0131	0.0202	CcSEcCtD
Rizatriptan—HTR1F—head—head and neck cancer	0.0101	0.0292	CbGeAlD
Rizatriptan—Lacrimation—Fluorouracil—head and neck cancer	0.00985	0.0151	CcSEcCtD
Rizatriptan—Dysaesthesia—Docetaxel—head and neck cancer	0.00966	0.0148	CcSEcCtD
Rizatriptan—Photophobia—Vinblastine—head and neck cancer	0.00828	0.0127	CcSEcCtD
Rizatriptan—MAOA—neck—head and neck cancer	0.00722	0.0209	CbGeAlD
Rizatriptan—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0072	0.0111	CcSEcCtD
Rizatriptan—Deafness—Vinblastine—head and neck cancer	0.00716	0.011	CcSEcCtD
Rizatriptan—Lacrimation—Docetaxel—head and neck cancer	0.00711	0.0109	CcSEcCtD
Rizatriptan—HTR1D—connective tissue—head and neck cancer	0.00679	0.0197	CbGeAlD
Rizatriptan—Eye irritation—Fluorouracil—head and neck cancer	0.00678	0.0104	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00653	0.01	CcSEcCtD
Rizatriptan—Disorientation—Hydroxyurea—head and neck cancer	0.00653	0.01	CcSEcCtD
Rizatriptan—Parosmia—Docetaxel—head and neck cancer	0.00644	0.00989	CcSEcCtD
Rizatriptan—Lacrimation increased—Fluorouracil—head and neck cancer	0.00628	0.00964	CcSEcCtD
Rizatriptan—Dysarthria—Fluorouracil—head and neck cancer	0.00612	0.00939	CcSEcCtD
Rizatriptan—MAOA—parotid gland—head and neck cancer	0.00588	0.017	CbGeAlD
Rizatriptan—Face oedema—Hydroxyurea—head and neck cancer	0.00564	0.00865	CcSEcCtD
Rizatriptan—MAOA—saliva-secreting gland—head and neck cancer	0.00563	0.0163	CbGeAlD
Rizatriptan—Photophobia—Fluorouracil—head and neck cancer	0.00544	0.00834	CcSEcCtD
Rizatriptan—Angina pectoris—Vinblastine—head and neck cancer	0.00539	0.00827	CcSEcCtD
Rizatriptan—Myocardial ischaemia—Docetaxel—head and neck cancer	0.0052	0.00798	CcSEcCtD
Rizatriptan—MAOA—connective tissue—head and neck cancer	0.00517	0.015	CbGeAlD
Rizatriptan—Rhinorrhoea—Docetaxel—head and neck cancer	0.00516	0.00792	CcSEcCtD
Rizatriptan—Euphoric mood—Fluorouracil—head and neck cancer	0.00498	0.00763	CcSEcCtD
Rizatriptan—Eye irritation—Docetaxel—head and neck cancer	0.00489	0.00751	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00486	0.00746	CcSEcCtD
Rizatriptan—Myocardial infarction—Vinblastine—head and neck cancer	0.00484	0.00742	CcSEcCtD
Rizatriptan—Photosensitivity—Fluorouracil—head and neck cancer	0.00479	0.00735	CcSEcCtD
Rizatriptan—Swelling—Fluorouracil—head and neck cancer	0.00476	0.00731	CcSEcCtD
Rizatriptan—Dysuria—Hydroxyurea—head and neck cancer	0.00472	0.00724	CcSEcCtD
Rizatriptan—Disorientation—Fluorouracil—head and neck cancer	0.0047	0.00721	CcSEcCtD
Rizatriptan—Lacrimation increased—Docetaxel—head and neck cancer	0.00454	0.00696	CcSEcCtD
Rizatriptan—Hypoaesthesia—Vinblastine—head and neck cancer	0.00441	0.00676	CcSEcCtD
Rizatriptan—Pharyngitis—Vinblastine—head and neck cancer	0.0044	0.00675	CcSEcCtD
Rizatriptan—Hearing impaired—Docetaxel—head and neck cancer	0.00439	0.00674	CcSEcCtD
Rizatriptan—MAOA—trachea—head and neck cancer	0.00434	0.0126	CbGeAlD
Rizatriptan—Osteoarthritis—Fluorouracil—head and neck cancer	0.0042	0.00645	CcSEcCtD
Rizatriptan—Blood pressure increased—Docetaxel—head and neck cancer	0.00418	0.00641	CcSEcCtD
Rizatriptan—HTR1B—head—head and neck cancer	0.00413	0.012	CbGeAlD
Rizatriptan—Hallucination—Hydroxyurea—head and neck cancer	0.00402	0.00617	CcSEcCtD
Rizatriptan—Irritability—Fluorouracil—head and neck cancer	0.00401	0.00616	CcSEcCtD
Rizatriptan—HTR1D—head—head and neck cancer	0.004	0.0116	CbGeAlD
Rizatriptan—Ataxia—Fluorouracil—head and neck cancer	0.00395	0.00607	CcSEcCtD
Rizatriptan—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00376	0.00577	CcSEcCtD
Rizatriptan—Muscular weakness—Fluorouracil—head and neck cancer	0.00371	0.00569	CcSEcCtD
Rizatriptan—Angiopathy—Hydroxyurea—head and neck cancer	0.00367	0.00562	CcSEcCtD
Rizatriptan—Dysphagia—Fluorouracil—head and neck cancer	0.00363	0.00557	CcSEcCtD
Rizatriptan—Chills—Hydroxyurea—head and neck cancer	0.00363	0.00556	CcSEcCtD
Rizatriptan—Angina pectoris—Fluorouracil—head and neck cancer	0.00354	0.00543	CcSEcCtD
Rizatriptan—Erythema—Hydroxyurea—head and neck cancer	0.00352	0.0054	CcSEcCtD
Rizatriptan—Vertigo—Vinblastine—head and neck cancer	0.00346	0.00532	CcSEcCtD
Rizatriptan—Swelling—Docetaxel—head and neck cancer	0.00344	0.00528	CcSEcCtD
Rizatriptan—MAOA—thyroid gland—head and neck cancer	0.00344	0.00995	CbGeAlD
Rizatriptan—Deafness—Docetaxel—head and neck cancer	0.00339	0.0052	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00338	0.00518	CcSEcCtD
Rizatriptan—Convulsion—Vinblastine—head and neck cancer	0.00334	0.00513	CcSEcCtD
Rizatriptan—HTR1A—head—head and neck cancer	0.00334	0.00966	CbGeAlD
Rizatriptan—Hypertension—Vinblastine—head and neck cancer	0.00333	0.00511	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00332	0.00509	CcSEcCtD
Rizatriptan—Discomfort—Vinblastine—head and neck cancer	0.00324	0.00498	CcSEcCtD
Rizatriptan—Hot flush—Docetaxel—head and neck cancer	0.00324	0.00498	CcSEcCtD
Rizatriptan—Menopausal symptoms—Docetaxel—head and neck cancer	0.00322	0.00493	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00319	0.0049	CcSEcCtD
Rizatriptan—Myocardial infarction—Fluorouracil—head and neck cancer	0.00318	0.00487	CcSEcCtD
Rizatriptan—Epistaxis—Fluorouracil—head and neck cancer	0.00306	0.00469	CcSEcCtD
Rizatriptan—MAOA—head—head and neck cancer	0.00305	0.00882	CbGeAlD
Rizatriptan—Convulsion—Hydroxyurea—head and neck cancer	0.00305	0.00468	CcSEcCtD
Rizatriptan—Anorexia—Vinblastine—head and neck cancer	0.003	0.0046	CcSEcCtD
Rizatriptan—Discomfort—Hydroxyurea—head and neck cancer	0.00296	0.00454	CcSEcCtD
Rizatriptan—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00289	0.00444	CcSEcCtD
Rizatriptan—Melatonin—CYP1A1—head and neck cancer	0.00289	1	CrCbGaD
Rizatriptan—Pharyngitis—Fluorouracil—head and neck cancer	0.00289	0.00443	CcSEcCtD
Rizatriptan—Oedema—Hydroxyurea—head and neck cancer	0.00287	0.0044	CcSEcCtD
Rizatriptan—CYP1A2—thyroid gland—head and neck cancer	0.00287	0.0083	CbGeAlD
Rizatriptan—Ataxia—Docetaxel—head and neck cancer	0.00285	0.00438	CcSEcCtD
Rizatriptan—Paraesthesia—Vinblastine—head and neck cancer	0.00283	0.00434	CcSEcCtD
Rizatriptan—Dehydration—Docetaxel—head and neck cancer	0.00282	0.00433	CcSEcCtD
Rizatriptan—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00281	0.00432	CcSEcCtD
Rizatriptan—Anorexia—Hydroxyurea—head and neck cancer	0.00274	0.0042	CcSEcCtD
Rizatriptan—Decreased appetite—Vinblastine—head and neck cancer	0.00274	0.0042	CcSEcCtD
Rizatriptan—Cramp muscle—Docetaxel—head and neck cancer	0.00273	0.00419	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00273	0.00419	CcSEcCtD
Rizatriptan—Nasopharyngitis—Docetaxel—head and neck cancer	0.00271	0.00416	CcSEcCtD
Rizatriptan—Constipation—Vinblastine—head and neck cancer	0.00269	0.00413	CcSEcCtD
Rizatriptan—Pain—Vinblastine—head and neck cancer	0.00269	0.00413	CcSEcCtD
Rizatriptan—Dysphagia—Docetaxel—head and neck cancer	0.00262	0.00402	CcSEcCtD
Rizatriptan—Arrhythmia—Fluorouracil—head and neck cancer	0.0026	0.00399	CcSEcCtD
Rizatriptan—Feeling abnormal—Vinblastine—head and neck cancer	0.00259	0.00398	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00257	0.00395	CcSEcCtD
Rizatriptan—Dyspnoea—Hydroxyurea—head and neck cancer	0.00256	0.00393	CcSEcCtD
Rizatriptan—Angina pectoris—Docetaxel—head and neck cancer	0.00255	0.00392	CcSEcCtD
Rizatriptan—Somnolence—Hydroxyurea—head and neck cancer	0.00255	0.00392	CcSEcCtD
Rizatriptan—Erythema—Fluorouracil—head and neck cancer	0.00253	0.00388	CcSEcCtD
Rizatriptan—Dyspepsia—Hydroxyurea—head and neck cancer	0.00253	0.00388	CcSEcCtD
Rizatriptan—Decreased appetite—Hydroxyurea—head and neck cancer	0.0025	0.00383	CcSEcCtD
Rizatriptan—Abdominal pain—Vinblastine—head and neck cancer	0.00249	0.00382	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00248	0.0038	CcSEcCtD
Rizatriptan—Fatigue—Hydroxyurea—head and neck cancer	0.00247	0.0038	CcSEcCtD
Rizatriptan—Pain—Hydroxyurea—head and neck cancer	0.00245	0.00377	CcSEcCtD
Rizatriptan—Constipation—Hydroxyurea—head and neck cancer	0.00245	0.00377	CcSEcCtD
Rizatriptan—Vision blurred—Fluorouracil—head and neck cancer	0.00239	0.00366	CcSEcCtD
Rizatriptan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00237	0.00363	CcSEcCtD
Rizatriptan—Hypersensitivity—Vinblastine—head and neck cancer	0.00232	0.00356	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Docetaxel—head and neck cancer	0.0023	0.00354	CcSEcCtD
Rizatriptan—Myocardial infarction—Docetaxel—head and neck cancer	0.00229	0.00352	CcSEcCtD
Rizatriptan—Body temperature increased—Hydroxyurea—head and neck cancer	0.00227	0.00348	CcSEcCtD
Rizatriptan—Asthenia—Vinblastine—head and neck cancer	0.00226	0.00347	CcSEcCtD
Rizatriptan—Epistaxis—Docetaxel—head and neck cancer	0.00221	0.00338	CcSEcCtD
Rizatriptan—Convulsion—Fluorouracil—head and neck cancer	0.00219	0.00337	CcSEcCtD
Rizatriptan—Chest pain—Fluorouracil—head and neck cancer	0.00216	0.00331	CcSEcCtD
Rizatriptan—Myalgia—Fluorouracil—head and neck cancer	0.00216	0.00331	CcSEcCtD
Rizatriptan—Diarrhoea—Vinblastine—head and neck cancer	0.00215	0.0033	CcSEcCtD
Rizatriptan—MAOA—lymph node—head and neck cancer	0.00213	0.00618	CbGeAlD
Rizatriptan—Discomfort—Fluorouracil—head and neck cancer	0.00213	0.00327	CcSEcCtD
Rizatriptan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00211	0.00325	CcSEcCtD
Rizatriptan—Hypoaesthesia—Docetaxel—head and neck cancer	0.00209	0.0032	CcSEcCtD
Rizatriptan—Confusional state—Fluorouracil—head and neck cancer	0.00208	0.0032	CcSEcCtD
Rizatriptan—Pharyngitis—Docetaxel—head and neck cancer	0.00208	0.0032	CcSEcCtD
Rizatriptan—Dizziness—Vinblastine—head and neck cancer	0.00208	0.00319	CcSEcCtD
Rizatriptan—Oedema—Fluorouracil—head and neck cancer	0.00207	0.00317	CcSEcCtD
Rizatriptan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00207	0.00317	CcSEcCtD
Rizatriptan—Asthenia—Hydroxyurea—head and neck cancer	0.00206	0.00316	CcSEcCtD
Rizatriptan—Nervous system disorder—Fluorouracil—head and neck cancer	0.00203	0.00311	CcSEcCtD
Rizatriptan—Tachycardia—Fluorouracil—head and neck cancer	0.00202	0.00309	CcSEcCtD
Rizatriptan—Vomiting—Vinblastine—head and neck cancer	0.002	0.00307	CcSEcCtD
Rizatriptan—Headache—Vinblastine—head and neck cancer	0.00197	0.00303	CcSEcCtD
Rizatriptan—Anorexia—Fluorouracil—head and neck cancer	0.00197	0.00302	CcSEcCtD
Rizatriptan—Diarrhoea—Hydroxyurea—head and neck cancer	0.00196	0.00301	CcSEcCtD
Rizatriptan—Flushing—Docetaxel—head and neck cancer	0.00195	0.00299	CcSEcCtD
Rizatriptan—Angiopathy—Docetaxel—head and neck cancer	0.0019	0.00292	CcSEcCtD
Rizatriptan—Dizziness—Hydroxyurea—head and neck cancer	0.0019	0.00291	CcSEcCtD
Rizatriptan—Chills—Docetaxel—head and neck cancer	0.00188	0.00289	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00188	0.00289	CcSEcCtD
Rizatriptan—Arrhythmia—Docetaxel—head and neck cancer	0.00188	0.00288	CcSEcCtD
Rizatriptan—Nausea—Vinblastine—head and neck cancer	0.00187	0.00287	CcSEcCtD
Rizatriptan—Insomnia—Fluorouracil—head and neck cancer	0.00187	0.00287	CcSEcCtD
Rizatriptan—Paraesthesia—Fluorouracil—head and neck cancer	0.00186	0.00285	CcSEcCtD
Rizatriptan—Dyspnoea—Fluorouracil—head and neck cancer	0.00184	0.00283	CcSEcCtD
Rizatriptan—Mental disorder—Docetaxel—head and neck cancer	0.00184	0.00282	CcSEcCtD
Rizatriptan—Somnolence—Fluorouracil—head and neck cancer	0.00184	0.00282	CcSEcCtD
Rizatriptan—Erythema—Docetaxel—head and neck cancer	0.00183	0.0028	CcSEcCtD
Rizatriptan—Vomiting—Hydroxyurea—head and neck cancer	0.00183	0.0028	CcSEcCtD
Rizatriptan—Dyspepsia—Fluorouracil—head and neck cancer	0.00182	0.00279	CcSEcCtD
Rizatriptan—Rash—Hydroxyurea—head and neck cancer	0.00181	0.00278	CcSEcCtD
Rizatriptan—Dermatitis—Hydroxyurea—head and neck cancer	0.00181	0.00277	CcSEcCtD
Rizatriptan—Headache—Hydroxyurea—head and neck cancer	0.0018	0.00276	CcSEcCtD
Rizatriptan—Decreased appetite—Fluorouracil—head and neck cancer	0.0018	0.00276	CcSEcCtD
Rizatriptan—Dysgeusia—Docetaxel—head and neck cancer	0.00179	0.00275	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00178	0.00274	CcSEcCtD
Rizatriptan—Pain—Fluorouracil—head and neck cancer	0.00177	0.00271	CcSEcCtD
Rizatriptan—Muscle spasms—Docetaxel—head and neck cancer	0.00176	0.0027	CcSEcCtD
Rizatriptan—Nausea—Hydroxyurea—head and neck cancer	0.0017	0.00262	CcSEcCtD
Rizatriptan—Feeling abnormal—Fluorouracil—head and neck cancer	0.0017	0.00261	CcSEcCtD
Rizatriptan—Urticaria—Fluorouracil—head and neck cancer	0.00164	0.00252	CcSEcCtD
Rizatriptan—Syncope—Docetaxel—head and neck cancer	0.00164	0.00251	CcSEcCtD
Rizatriptan—Body temperature increased—Fluorouracil—head and neck cancer	0.00163	0.00251	CcSEcCtD
Rizatriptan—Palpitations—Docetaxel—head and neck cancer	0.00161	0.00248	CcSEcCtD
Rizatriptan—Loss of consciousness—Docetaxel—head and neck cancer	0.00161	0.00246	CcSEcCtD
Rizatriptan—Cough—Docetaxel—head and neck cancer	0.00159	0.00245	CcSEcCtD
Rizatriptan—Convulsion—Docetaxel—head and neck cancer	0.00158	0.00243	CcSEcCtD
Rizatriptan—Hypertension—Docetaxel—head and neck cancer	0.00158	0.00242	CcSEcCtD
Rizatriptan—Arthralgia—Docetaxel—head and neck cancer	0.00156	0.00239	CcSEcCtD
Rizatriptan—Myalgia—Docetaxel—head and neck cancer	0.00156	0.00239	CcSEcCtD
Rizatriptan—Chest pain—Docetaxel—head and neck cancer	0.00156	0.00239	CcSEcCtD
Rizatriptan—Hypersensitivity—Fluorouracil—head and neck cancer	0.00152	0.00234	CcSEcCtD
Rizatriptan—Dry mouth—Docetaxel—head and neck cancer	0.00152	0.00233	CcSEcCtD
Rizatriptan—Confusional state—Docetaxel—head and neck cancer	0.0015	0.00231	CcSEcCtD
Rizatriptan—Anaphylactic shock—Docetaxel—head and neck cancer	0.00149	0.00229	CcSEcCtD
Rizatriptan—Oedema—Docetaxel—head and neck cancer	0.00149	0.00229	CcSEcCtD
Rizatriptan—Shock—Docetaxel—head and neck cancer	0.00147	0.00225	CcSEcCtD
Rizatriptan—Nervous system disorder—Docetaxel—head and neck cancer	0.00146	0.00224	CcSEcCtD
Rizatriptan—Pruritus—Fluorouracil—head and neck cancer	0.00146	0.00224	CcSEcCtD
Rizatriptan—Tachycardia—Docetaxel—head and neck cancer	0.00146	0.00223	CcSEcCtD
Rizatriptan—Anorexia—Docetaxel—head and neck cancer	0.00142	0.00218	CcSEcCtD
Rizatriptan—Diarrhoea—Fluorouracil—head and neck cancer	0.00141	0.00217	CcSEcCtD
Rizatriptan—Dizziness—Fluorouracil—head and neck cancer	0.00137	0.0021	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00136	0.00208	CcSEcCtD
Rizatriptan—Insomnia—Docetaxel—head and neck cancer	0.00135	0.00207	CcSEcCtD
Rizatriptan—Paraesthesia—Docetaxel—head and neck cancer	0.00134	0.00205	CcSEcCtD
Rizatriptan—Dyspnoea—Docetaxel—head and neck cancer	0.00133	0.00204	CcSEcCtD
Rizatriptan—Somnolence—Docetaxel—head and neck cancer	0.00133	0.00203	CcSEcCtD
Rizatriptan—Vomiting—Fluorouracil—head and neck cancer	0.00131	0.00202	CcSEcCtD
Rizatriptan—Dyspepsia—Docetaxel—head and neck cancer	0.00131	0.00201	CcSEcCtD
Rizatriptan—Rash—Fluorouracil—head and neck cancer	0.0013	0.002	CcSEcCtD
Rizatriptan—Dermatitis—Fluorouracil—head and neck cancer	0.0013	0.002	CcSEcCtD
Rizatriptan—Decreased appetite—Docetaxel—head and neck cancer	0.0013	0.00199	CcSEcCtD
Rizatriptan—Headache—Fluorouracil—head and neck cancer	0.00129	0.00199	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00129	0.00198	CcSEcCtD
Rizatriptan—Fatigue—Docetaxel—head and neck cancer	0.00129	0.00197	CcSEcCtD
Rizatriptan—Constipation—Docetaxel—head and neck cancer	0.00128	0.00196	CcSEcCtD
Rizatriptan—Pain—Docetaxel—head and neck cancer	0.00128	0.00196	CcSEcCtD
Rizatriptan—Feeling abnormal—Docetaxel—head and neck cancer	0.00123	0.00189	CcSEcCtD
Rizatriptan—Nausea—Fluorouracil—head and neck cancer	0.00123	0.00188	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00122	0.00187	CcSEcCtD
Rizatriptan—Body temperature increased—Docetaxel—head and neck cancer	0.00118	0.00181	CcSEcCtD
Rizatriptan—Abdominal pain—Docetaxel—head and neck cancer	0.00118	0.00181	CcSEcCtD
Rizatriptan—Hypersensitivity—Docetaxel—head and neck cancer	0.0011	0.00169	CcSEcCtD
Rizatriptan—Asthenia—Docetaxel—head and neck cancer	0.00107	0.00164	CcSEcCtD
Rizatriptan—Pruritus—Docetaxel—head and neck cancer	0.00106	0.00162	CcSEcCtD
Rizatriptan—Diarrhoea—Docetaxel—head and neck cancer	0.00102	0.00157	CcSEcCtD
Rizatriptan—Dizziness—Docetaxel—head and neck cancer	0.000986	0.00151	CcSEcCtD
Rizatriptan—Vomiting—Docetaxel—head and neck cancer	0.000948	0.00145	CcSEcCtD
Rizatriptan—Rash—Docetaxel—head and neck cancer	0.00094	0.00144	CcSEcCtD
Rizatriptan—Dermatitis—Docetaxel—head and neck cancer	0.000939	0.00144	CcSEcCtD
Rizatriptan—Headache—Docetaxel—head and neck cancer	0.000934	0.00143	CcSEcCtD
Rizatriptan—Nausea—Docetaxel—head and neck cancer	0.000886	0.00136	CcSEcCtD
